Taro Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Will market "several" topical dermatological and vaginal OTC products under an agreement with Schering-Plough that results from a previously announced joint research effort, Hawthorne, N.Y.-based Taro announces March 12. The two firms announced a joint R&D agreement on certain topicals in April 1998 ("The Tan Sheet" April 27, 1998, In Brief). Distribution of the products is expected to begin in the first half with additional products slated for introduction in the first quarter 2000. Taro will distribute the products under its own label and under various private label customers' OTC labels, the firm notes. Taro already markets topical 1% clotrimazole for athlete's foot and jock itch, which is comparable to Schering's Lotrimin AF. Clotrimazole also is the active ingredient in Schering vaginal yeast infection treatment Gyne-Lotrimin
You may also be interested in...
Private Label Three-Day Yeast Infection Cream Offered By Taro
Taro Pharmaceutical Industries' new drug application for clotrimazole 2% three-day cream was approved April 14 as a private label OTC vaginal yeast infection treatment identical to Schering-Plough's Gyne-Lotrimin 3 Cream. The product will appear on store shelves of major chains and mass merchandisers beginning in May.
Private Label Three-Day Yeast Infection Cream Offered By Taro
Taro Pharmaceutical Industries' new drug application for clotrimazole 2% three-day cream was approved April 14 as a private label OTC vaginal yeast infection treatment identical to Schering-Plough's Gyne-Lotrimin 3 Cream. The product will appear on store shelves of major chains and mass merchandisers beginning in May.
Private Label Three-Day Yeast Infection Cream Offered By Taro
Taro Pharmaceutical Industries' new drug application for clotrimazole 2% three-day cream was approved April 14 as a private label OTC vaginal yeast infection treatment identical to Schering-Plough's Gyne-Lotrimin 3 Cream. The product will appear on store shelves of major chains and mass merchandisers beginning in May.